Search research articles
Contact Us
Filters
Showing results (191-200 of 219) with videos related to
Page
of 22
Sort By:
Schizophrenia Bulletin
|
November 18, 2008
Supportive evidence for reduced expression of GNB1L in schizophrenia
Hiroki Ishiguro, Minori Koga, Yasue Horiuchi, et al.
Human Molecular Genetics
|
April 14, 2009
Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia
Minori Koga, Hiroki Ishiguro, Saori Yazaki, et al.
Plos One
|
February 21, 2008
Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects
Emmanuel S Onaivi, Hiroki Ishiguro, Jian-Ping Gong, et al.
Human Genome Variation
|
December 10, 2020
Rare single-nucleotide DAB1 variants and their contribution to Schizophrenia and autism spectrum disorder susceptibility
Yoshihiro Nawa, Hiroki Kimura, Daisuke Mori, et al.
Nordic Journal of Psychiatry
|
June 26, 2020
Dyskinesia is most centrally situated in an estimated network of extrapyramidal syndrome in Asian patients with schizophrenia: findings from research on Asian psychotropic prescription patterns for antipsychotics
Seon-Cheol Park, Gyung-Mee Kim, Takahiro A Kato, et al.
Nordic Journal of Psychiatry
|
June 27, 2019
Cannabis use correlates with aggressive behavior and long-acting injectable antipsychotic treatment in Asian patients with schizophrenia
Seon-Cheol Park, Hong Seok Oh, Adarsh Tripathi, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists
|
March 19, 2026
Pharmacoepidemiologic Trends and Factors Associated With Use and Dosing of Newer Antidepressants in 8357 Patients Across Asia: A Two-Decade Perspective
Jiangbo Ying, Qian Hui Chew, Tian-Mei Si, et al.
Annals of the New York Academy of Sciences
|
November 11, 2008
Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression
Emmanuel S Onaivi, Hiroki Ishiguro, Jian-Ping Gong, et al.
Human Psychopharmacology
|
December 3, 2022
The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study
Chika Kubota, Toshiya Inada, Shih-Ku Lin, et al.
Biological Psychiatry
|
September 14, 2010
Genome-wide association study of schizophrenia in a Japanese population
Masashi Ikeda, Branko Aleksic, Yoko Kinoshita, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 219) with videos related to
Sort By:
Page
of 22
Schizophrenia Bulletin
|
November 18, 2008
Supportive evidence for reduced expression of GNB1L in schizophrenia
Hiroki Ishiguro, Minori Koga, Yasue Horiuchi, et al.
Human Molecular Genetics
|
April 14, 2009
Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia
Minori Koga, Hiroki Ishiguro, Saori Yazaki, et al.
Plos One
|
February 21, 2008
Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects
Emmanuel S Onaivi, Hiroki Ishiguro, Jian-Ping Gong, et al.
Human Genome Variation
|
December 10, 2020
Rare single-nucleotide DAB1 variants and their contribution to Schizophrenia and autism spectrum disorder susceptibility
Yoshihiro Nawa, Hiroki Kimura, Daisuke Mori, et al.
Nordic Journal of Psychiatry
|
June 26, 2020
Dyskinesia is most centrally situated in an estimated network of extrapyramidal syndrome in Asian patients with schizophrenia: findings from research on Asian psychotropic prescription patterns for antipsychotics
Seon-Cheol Park, Gyung-Mee Kim, Takahiro A Kato, et al.
Nordic Journal of Psychiatry
|
June 27, 2019
Cannabis use correlates with aggressive behavior and long-acting injectable antipsychotic treatment in Asian patients with schizophrenia
Seon-Cheol Park, Hong Seok Oh, Adarsh Tripathi, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists
|
March 19, 2026
Pharmacoepidemiologic Trends and Factors Associated With Use and Dosing of Newer Antidepressants in 8357 Patients Across Asia: A Two-Decade Perspective
Jiangbo Ying, Qian Hui Chew, Tian-Mei Si, et al.
Annals of the New York Academy of Sciences
|
November 11, 2008
Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression
Emmanuel S Onaivi, Hiroki Ishiguro, Jian-Ping Gong, et al.
Human Psychopharmacology
|
December 3, 2022
The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study
Chika Kubota, Toshiya Inada, Shih-Ku Lin, et al.
Biological Psychiatry
|
September 14, 2010
Genome-wide association study of schizophrenia in a Japanese population
Masashi Ikeda, Branko Aleksic, Yoko Kinoshita, et al.
Page
of 22